What You Need to Know About Bipolar Depression

Know that bipolar disorder is one type of condition that would affect all kinds of people. Both children and adults would get affected by such kind of condition. Such is a fact that you must understand. Those women would suffer the most from such type of depression which is known as bipolar depression disorder.

This isn’t very strange or far-fetched in any case, since even when the women would suffer from such regular bipolar kind of depression or the depressive disorder, they would often spend more time depressed than they do being manic. Not only women are depressive but the men also are and they could also be affected by this condition.

The bipolar type of disorder is known as manic depression because this is a mental condition wherein you would interchange often between the phases of mania and depression. If you suffer from such bipolar depression, you won’t have to spend a lot of time being manic as you spend getting depressed.

This kind of depression is one form of disorder and you should understand it is easy to wrongly diagnose as bipolar disorder due to the similarity of such symptoms. Because of such, the doctor must keep you around for such a long time when they would try to diagnose the condition you have. It is definitely not flattering to either of you if you would be treated for a wrong thing.

Such bipolar affective disorder is another name for the bipolar disorder or such manic-depressive illness. But, you don’t like to mistake this for bipolar depression disorder. Such is closely related with all of the symptoms of such depressive phase of the bipolar disorder, but very few of the mania.

The monotherapy trials from placebo is actually the gold-standard design in knowing the efficacy when it comes to the treatment of bipolar depression. If the efficacy would get proven as monotherapy, those new compounds can be tested in the adjunctive-medication placebo-controlled trials. Those younger adults, without the established need for such long-term medication can be suitable for the clinical trials needing placebo-controls. Such switch to mania or the hypomania can perhaps be the result of the active treatment for such bipolar depression.

Some of the medications like the tricyclic antidepressants as well as venlafaxine can be more likely to prove switch than the others but the increased rate of the switch cannot be seen until around ten weeks of treatment. The 12-week trials against placebo are needed to determine the risk of switch and also to establish the continuing effects. Know that such careful assessments at six to eight weeks are needed to ensure that the patients who fail to respond don’t continue in the study for such unacceptable periods of time.